Original Research

Goiter, iodine bioavailability and intrauterine growth restriction in Indigenous and Afro-descendant pregnant women from six non-metropolitan areas of Colombia (2019–2020)

AUTHORS

name here
Julian A Herrera-Murgueitio
1 PhD, Emeritus and Honorary Professor of Medicine * ORCID logo

name here
Octavio Piñeros
1 MBA, Professor ORCID logo

name here
Javier Torres Munoz
2 MD, Associate Professor ORCID logo

name here
Mildrey Mosquera Escudero
3 PhD, Leader of the Nutrition Research Group ORCID logo

name here
Marco A Tamara Burgos
4 MD, MPH, Health Professional ORCID logo

name here
Maria M Arriola-Salgado
5 MPH, Assistant Professor ORCID logo

name here
Elia J Gomez-Porras
6 Health Professional ORCID logo

name here
Sandra X Cespedes Gaitan
7 MD, MSc, Obstetrician and Gynecologist ORCID logo

name here
Ana M Galvis-Serrano
8 MSc, Director

name here
Wilman A Suarez Izquierdo
9 MD, MSc, Medical Epidemiologist ORCID logo

name here
Erika J Umaña
1 MD, Assistant Professor ORCID logo

name here
Ana Y Forero Torres
10 MSc, Director ORCID logo

name here
Anibal N Díaz
11 MD, PhD, Chief ORCID logo

CORRESPONDENCE

*Prof Emer Julian A Herrera-Murgueitio

AFFILIATIONS

1 Department of Family Medicine, School of Medicine, Universidad del Valle, Cali, Colombia

2 Neonatology Section, Department of Pediatrics, Universidad del Valle, Cali, Colombia

3 Biochemistry Section, School of Basic Sciences, Faculty of Health, Universidad del Valle, Cali, Colombia

4 Departmental Secretary of Cordoba, ESE Hospital San Jerónimo, Montería, Córdoba, Colombia

5 Universidad de Córdoba, Montería, Córdoba, Colombia

6 Secretaria de Salud, Gobernación del Amazonas, Leticia, Amazonas, Colombia

7 Clínica Marta, Villavicencio, Meta, Colombia

8 Baylor Foundation, Riohacha, La Guajira, Colombia

9 Gonawindua Indigenous Public Health Institution, Sierra Nevada de Santa Marta, Colombia

10 Nutrition Section, National Health Institute, Ministry of Health and Social Protection, Bogotá, Colombia

11 Gynecology and Obstetrics Service, Hospital Virgen de la Arrixaca, Universidad de Murcia, Murcia, Spain

PUBLISHED

29 September 2024 Volume 24 Issue 3

HISTORY

RECEIVED: 13 July 2023

REVISED: 1 February 2024

ACCEPTED: 30 April 2024

CITATION

Herrera-Murgueitio JA, Piñeros O, Torres Munoz J, Mosquera Escudero M, Tamara Burgos MA, Arriola-Salgado MM, Gomez-Porras EJ, Cespedes Gaitan SX, Galvis-Serrano AM, Suarez Izquierdo WA, Umaña EJ, Forero Torres AY, Díaz AN.  Goiter, iodine bioavailability and intrauterine growth restriction in Indigenous and Afro-descendant pregnant women from six non-metropolitan areas of Colombia (2019–2020). Rural and Remote Health 2024; 24: 8587. https://doi.org/10.22605/RRH8587

AUTHOR CONTRIBUTIONSgo to url

This work is licensed under a Creative Commons Attribution 4.0 International Licence


abstract:

Introduction:  Iodine is an essential mineral for fetal growth and brain development. The aim of this research was to evaluate goiter, iodine deficiency and intrauterine growth restriction in pregnant women of minority ethnic groups in Colombia.
Methods:  A cross-sectional study was performed in six non-metropolitan areas of Colombia.
Results:  A total of 318 Indigenous and Afro-descendant pregnant women were invited to participate: 248 (83.2%) Indigenous and 50 (16.8%) Afro-descendants were studied. The mean age was 24 years (range 13–44 years). Of the women, 130 (43.5%) were from the department of Cauca, 72 (24.1%) were from Córdoba, 28 (9.4%) were from Guajira, 26 (8.8%) were from Sierra Nevada de Santa Marta, 22 (7.4%) were from Amazonas, 16 (5.4%) were from Meta and 4 (1.3%) were from the department of Cesar. A total of 244 (81.8%) were illiterate and 291 (97.7%) were of very low socioeconomic level. Goiter was observed in 69 (23.3%) pregnant women (38 (41.7%) from the department of Cauca, 10 (35.7%) from Guajira, 5 (31.2%) from Meta, 6 (27.2%) from Amazonas and 10 (13.8%) from Córdoba). Iodine deficiency (<100 µg/L) was observed in 42 (14.9%) pregnant women (16 (11.6%) mild (50–99 µg/L), 19 (13.8%) moderate (20–49 µg/L) and 7 (5.1%) severe (<20 µg/L)). Being literate was a protective factor for iodine deficiency (odds ratio (OR)=0.19, 95% confidence interval (CI) 0.04–0.84, p=0.016). Being illiterate and iodine deficient was only a risk factor for goiter (OR=6.72, 95%CI 3.9–9.5, p=0.038) in the department of Cauca.
Conclusion:  A high prevalence of goiter, iodine deficiency and intrauterine growth restriction was observed in minority ethnic groups of Colombia. The highest prevalence and risk was observed in the department of Cauca.

Keywords:

Afro-descendants, Colombia, goiter, Indigenous, intrauterine growth restriction, iodine deficiency, pregnancy, social determinants.

full article:

Introduction

Pregnancy increases the requirement for iodine by at least 50%, and a lack of iodine in the diet can result in maternal iodine deficiency. In the fetus1, iodine concentrations of less than 50 mg/L can increase concentrations of thyroid stimulating hormone (TSH) and the risk of goiter2. The causal relationship between iodine deficiency, goiter and congenital hypothyroidism has been described3. Maternal thyroxine crosses the placenta before the onset of fetal thyroid function (weeks 10–12) and accounts for 20–40% of maternal thyroxine measured in cord blood at birth. Thyroid hormones are necessary for neuronal migration and myelination; iodine deficiency irreversibly impairs fetal brain development and increases the risk of stillbirth, miscarriage and congenital anomalies4. Severe iodine deficiency results in maternal and fetal hypothyroidism and associated serious adverse health effects, including congenital hypothyroidism and growth retardation. Birth weight can be affected by slight variations in normal maternal thyroid hormone levels4-6. Excess iodine in the diet of pregnant women can induce factitious hyperthyroidism7. The World Health Organization (WHO) recognizes that in Colombia there is no iodine deficiency in the general population7,8. The few studies available in Latin America are limited to children in metropolitan areas and not to pregnant women in non-metropolitan areas. A descriptive cross-sectional analytical study was conducted to determine the prevalence of the above conditions in six non-metropolitan areas of Colombia.

Methods

Pregnant patients from Indigenous and Afro-descendant towns and institutions that provide health services of the departments of Amazonas, Cauca, Cesar, Córdoba, Guajira and Meta, who were insured in the General System of Social Security in Health, were invited to participate if a signed informed consent was evaluated. The protocol was reviewed and approved by the departmental governments through the departmental health secretariats and their Indigenous affairs offices. It was also submitted for consideration by the Indigenous communities and approved by the Indigenous governors of the respective ethnic groups. The number of patients in each territorial entity was proportional to the number of Indigenous and Afro-descendant insured pregnant women in the territory. The sample was calculated with a margin error of 5 percentage points and 80% power. The sample was overestimated by 10% because of the potential loss of patients and/or urine samples during river, land, or air transport. The pilot test was conducted in the municipalities of Northern Cauca (Corinto, Puerto Tejada and Santander de Quilichao) to determine the degree of understanding of the questions in the questionnaire and to establish the prevalence of iodine deficiency in the Indigenous and Afro-descendant populations. With these data, the sample was established for the Indigenous and Afro-descendant population of six non-metropolitan areas of Colombia in the other departments. Translators of native language to Spanish were used when necessary.

The pregnant patients were recruited during 2019 (January to August). A descriptive cross-sectional analytical study was conducted. Sociodemographic, clinical and thyroid palpation characteristics were collected by means of a precoded form and by patient interview and physical examination of the patient included in the study. Only data from fetal growth were obtained from patient medical history record; the remaining clinical data were obtained directly and face to face with the pregnant patient by means of physical medical examination. Inclusion criteria were pregnant women in prenatal control recognized by self as Indigenous or Afro-descendant, without pathologies triggered by pregnancy (preeclampsia, preterm delivery, gestational diabetes) and with a reliable gestational age according to previous obstetric ultrasound, whose residence was in a non-metropolitan area. The exclusion criteria were having underlying diseases involving a hypo-sodium diet (heart failure, chronic arterial hypertension, chronic renal failure) or under-treatment for chronic non-communicable diseases, or having previous thyroid pathologies or under-treatment for the same, or who had not freely accepted their participation in the study, or who ingested daily multivitamins with supplemented concentrations of iodine.

The dependent variable was the presence of goiter and intrauterine growth restriction (IUGR). The presence of goiter was established by clinical evaluation7. Only one experimentally trained researcher evaluated the presence of goiter in all pregnant women included in the study to reduce the interoperator bias in the clinical evaluation. Goiter level 1 was determined when the thyroid gland was palpable by hyperextension of the neck, goiter level 2 when the thyroid was palpable without hyperextension of the neck, and goiter level 3 when the goiter was visible without palpation3. IUGR was determined by ultrasonography (fetal growth < 10th percentile). The independent variables were the assessment of iodine levels in spontaneous urinary samples and iodine levels in sal de cocina (cooking salt) collected in the home of the pregnant women recruited in the study. Sociodemographic characteristics were evaluated according to the criteria of the National Administrative Department of Statistics (DANE) and their classification (very poor socioeconomic income, stratum 1; medium socioeconomic income, stratum 3; very high socioeconomic income, stratum 6). Social determinants were evaluated according to the National Survey of Health and Demography (ENDS 2015). The database was provided for research purposes by PROFAMILIA Colombia (non-government organization) Bogotá DC, Colombia.

The urine sample was collected under conditions of perineal cleanliness and good hydration of the pregnant woman. Subsequently, a physical evaluation of the thyroid gland was performed and, if goiter was found, it was classified according to the classification previously defined by WHO7. The laboratory tests were processed by the Nutrition Laboratory of the Faculty of Health of the Universidad del Valle. The confounder variables were the sociodemographic characteristics, drinking and smoking habits in the pregnant women recruited in the study.

Urine samples collected in rural Indigenous and Afro-descendant communities in non-metropolitan areas were preserved and kept in cold chain at –20ºC until analysis. The urine samples were delivered without identifying the patient by name, only by a code, depending on the site where they came from, with a consecutive assignment number (AZ, Amazonas; CE, Cesar; SQ, Cauca; MI, Córdoba; GU, Guajira; MT, Meta). The laboratory reported blind results only with the code, without knowing their origin. The technique used by the laboratory was the colorimetric method with arsenic ion, validated by WHO for this type of study9. For quality control purposes, it was established that the laboratory results would have a blind counter-sample analysis, processed at the Vírgen de la Arrixaca University Hospital of the University of Murcia (Murcia, Spain). The gestational age was placed within the gestational trimester (TI, between verification of pregnancy and week 13 of gestation; TII, between weeks 14 and 28 of gestation; TIII, between weeks 29 and 42 of gestation). Gestational age corresponded to weeks of amenorrhea correlated with early obstetric ultrasonography, when available. Analytic mass spectrophotometry was performed in the chemical laboratory of the Faculty of Sciences of the Universidad del Valle. All the study data were recorded in an Access database, checked and exported to the general database. Univariate and bivariate analyses between dependent variables and independent variables were performed. Odds ratios (OR) with a 95% confidence interval (CI) were calculated. A logistic regression was performed. A multiple correspondence analysis was performed to identify the geographical location of iodine deficiency by regions. To determine the statistical significance, a p-value <0.05 was considered significant.

Ethics approval

The protocol was approved by the institutional ethics committee of the Faculty of Health of Universidad del Valle in Cali, Colombia (Act 006-19R).

Results

A total of 318 Indigenous and Afro-descendant pregnant women were invited to participate in the study; 298 (94.3%) met the inclusion criteria and agreed to voluntarily sign the informed consent form. Four patients were excluded from the study because despite having voluntarily agreed to participate and having the objectives of the study explained to them, they refused to collect and submit the urine sample. Fourteen patients were excluded because urinary tract infection was detected with the sample collected and they were referred for medical consultation. Two patients were excluded due to the loss of cold chain in air transport. We analyzed the results of 298 patients. The delivery of the recruited pregnant women was before the pandemic emergency of COVID-19 (March 2020).

The mean age of the recruited pregnant women was 24 years (range 13–44 years). Sociodemographic characteristics of the pregnant patients (Table 1) showed that they were from poor geographic areas with low educational level. Twelve (4.0%) pregnant women had an ultrasound diagnosis of intrauterine growth restriction (IUGR), which was found in their clinical history. Five (40.8%) pregnant women with IUGR were from Cauca, three (25.0%) were from Córdoba, two (16.7%) were from Amazonas, one (8.3%) was from Meta, and one (8.3%) was from Guajira. Three women (1.0%) reported having consumed alcohol and none reported having smoked during their pregnancy.

A total of 69 (23.3%) pregnant women were observed to have goiter (38 (41.7%) living in the department of Cauca, 10 (35.7%) in Guajira, 5 (31.2%) in Meta, 6 (27.2%) in Amazonas, 10 (13.8%) in Córdoba (p=0.0001)). Of the urine samples, 41 (13.7%) were collected in the first trimester of gestation, 103 (34.6%) in the second trimester, and 154 (51.7%) in the third trimester. Of the 42 (14.9%) pregnant women observed to have an iodine deficiency (<100 µg/L), 41 (16.5%) were Indigenous, and 1 (2.0%) was Afro-descendant (p=0.04); 7 (5.1%) were severely iodine deficient (<20 µg/L), 19 (13.8%) were moderately iodine deficient (20–49 µg/L) and 16 (11.6%) were mildly iodine deficient (50–99 µg/L). A total of 31 (22.5%) pregnant women had high urinary iodine levels (300–399 µg/L) and 14 (10.1%) had very high (400–499 µg/L) urinary iodine levels.

Being literate was observed to be a protective factor against iodine deficiency (<100 µg/L) (OR=0.19, 95%CI 0.04–0.84, p=0.016). Illiteracy was more frequent with severe iodine deficiency (62%) than with moderate iodine deficiency (4%) and without iodine deficiency (20%). In the department of Cauca, it was observed that illiteracy and iodine deficiency (<100 µg/L) were associated with goiter (OR=6.72, 95%CI 3.9–9.5, p=0.038). The department of Amazonas was observed to have the highest frequency of severe iodine deficiency (Fig1).

The median of iodine levels in cooking salt was 14.91 ppm (range 3.95–62.02 ppm). Both Indigenous and Afro-descendant pregnant women had very low levels of iodine in cooking salt (median Indigenous: 11.97 ppm (range 3.91–39.04 ppm); median Afro-descendant pregnant women: 18.36 ppm (range 12.31–62.02 ppm)) without statistical differences by ethnic factor.

Table 1:  Sociodemographic characteristics of the patients’ non-metropolitan geographic areas (2019)table image

Discussion

Among the pregnant women, 42 (14.9%) were observed to have iodine deficiency (<100 µg/L), 69 (23.3%) had goiter, and 12 (4.0%) had an ultrasound diagnosis of IUGR. For pregnant women, a high incidence of goiter and iodine deficiency was observed. The relevance of the results is that there are no studies on pregnant women in Indigenous and Afro-descendant communities residing in non-metropolitan areas in Latin America. The common denominator in the non-metropolitan areas is unsatisfied basic needs, food insecurity, low socioeconomic level, illiteracy, poor communication routes, low socioeconomic level and low quality of life. This situation is similar in all non-metropolitan areas and it’s not a variable of confusion; all areas were comparable according to their socioeconomic characteristics (Table 2). Considering the adverse geographical conditions and the low educational level of the pregnant women included in this study, it was not possible to collect 24-hour urine samples in the fieldwork. However, the measurement of urinary iodine in spontaneous urine is a good indicator of recent iodine intake, since more than 90% of dietary iodine appears in urine over time and can be extrapolated to daily iodine intake. This quantification of iodine does not provide direct information about thyroid function; a low value indicates that a population is at increased risk of developing thyroid disorders. This evaluation is recommended by WHO/International Council for the Control of Iodine Deficiency Disorders/UNICEF to assess iodine nutrition in pregnant women as a community screening test7. According to the results of the present study, in the non-metropolitan area, the major proportion of severe iodine deficiency was in the department of Amazonas (Fig1). Severe iodine deficiency has potential risks for impaired cognitive, neurological, and growth and developmental function in children10-12. The department of Córdoba had the highest proportion of moderate iodine deficiency (20–49 µg/L). It is recognized that cognitive deficits are associated with iodine deficiency in children, which cannot be limited to severe deficiencies, given that mild to moderate iodine deficiency in pregnancy somewhat affects the cognitive function and intelligence of children, as reported by some observers13,14. Iodine deficiency is a risk for fetal brain development and brain growth and development in intrauterine life; however, iodine excess is also a risk, as it can lead to factitious hyperthyroidism. The analytic observational descriptive study design identified excess levels of urinary iodine levels in the department of Cauca when the urinary samples were obtained (Fig1); however, in the same department, a high prevalence of goiter and high risk of having goiter was observed, probably because in the past these pregnant women were exposed at least to chronic iodine deficiency with increases of TSH4.

Multiple correspondence analysis identified the department of Cauca as having the highest iodine levels (Fig1), which corresponds to the time of the study; however, it was also the department with the highest prevalence (41.7%) (p=0.0001) of goiter (sustained iodine levels <50 µg/L) (capable of increasing TSH). As is known, thyroid hormone in pregnancy not only facilitates neuronal connections but also favors fetal growth and development, a plausible concept with the results of this study, where the only department with high risk to goiter and with high incidence of intrauterine growth restriction was the department of Cauca. It was surprising to observe how iodine deficiency (<100 µg/L) was more frequent in the Indigenous pregnant women and almost absent in the Afro-descendant pregnant women, given that both ethnic groups resided in the same non-metropolitan populations. We believe that cultural factors in these ethnic groups could partly explain this situation.

According to the criteria of WHO, this study has identified a public health problem, not known before, since it has been said that there was no iodine deficiency in the country because salt is fortified with iodine. However, these studies were conducted in metropolitan areas of the country, where the situation is different from that observed in minority and vulnerable populations in non-metropolitan areas. WHO considers that a goiter prevalence higher than 5% in pregnant women in a community should be considered a public health emergency7, since iodine deficiency in pregnancy is the main cause of mental retardation and avoidable cerebral palsy7. In this study, we identified two problems probably related to the iodine deficiency in urinary samples and very low levels of iodine in cooking salt. Further studies are needed to clarify if these are independent problems, or if they are or are not correlated.

In developed countries such as Australia, for example, iodine levels have been observed to be lower in the Indigenous population than in the non-Indigenous population. When comparing iodine levels among pregnant women of the Indigenous population according to place of residence, lower levels were observed in those Indigenous people who resided in non-metropolitan areas, than in those who resided in metropolitan areas15, which is consistent with the results of the present study. It has been shown that infant survival improves when iodine deficiency is corrected before or during pregnancy, and neonatal mortality can be reduced by up to 65% when the population at risk is supplemented with iodine during pregnancy16. In countries where cooking salt is not fortified with iodine, the prevalence of congenital hypothyroidism in children assessed at 4 years is higher11-14. Preventive treatment of iodine deficiencies should be a goal as should avoiding high iodine levels in pregnancy17. One of the strengths of this study was that the pregnant women were evaluated in their territories with the approval of their Indigenous authorities. Second, all regions of the country were included in the study. The very low level of schooling and socioeconomic status of the population studied were limitations of the study; however, the social determinants are similar without differences17.

The date of the pregnancy was not reliable and access to an obstetric ultrasound was an important limitation; therefore, we used the evaluation of the uterine height to determine the trimester. The measurement of the fundal height is helpful only when it is a single fetus, when it is taken by trained health personnel, with the bladder evacuated, and ultrasound is not available17.

An analytical descriptive study does not allow the determination of causal relationships, since there is no temporality; it only allows the generation of hypotheses. The usefulness of the present study is that it identified a public health problem, not previously visualized, because previous studies of the prevalence of iodine deficiency were conducted mostly in metropolitan areas, where few patients from minority populations were included7,18. The effect of iodine deficiency during pregnancy and its long-term effects on cognitive and growth and developmental aspects need to be clarified in Indigenous pregnant women residing in non-metropolitan areas.

Table 2:  Social determinants of health in the Indigenous and non-Indigenous populationstable image

table image Figure 1:  Multiple correspondence analysis between urinary iodine levels and non-metropolitan geographic areas (2019).

Conclusion

In pregnant women of minority ethnic groups of non-metropolitan areas of Colombia, a high prevalence of goiter, iodine deficiency and IUGR was observed, with regional differences. The department of Cauca was the only one with high risk of goiter.

Acknowledgements

The authors would like to thank the different governors’ offices, their departmental health secretariats, their Indigenous affairs offices, and the healthcare institutions of the different departments for their collaboration in the realization of this study. The authors would like to thank the statistician and epidemiologist Jennifer Murillo Alvarado for her contribution to the independent reporting of the results of this study.

Funding

Funding was received from the Universidad del Valle (Grant 1852-18).

Conflicts of interest

The authors declare that they have no institutional or personal interest in the objectives of the research or in the development of the project.

references:

1 Rodríguez A, Sanz FE, González RL. Yodo y gestación. [In Spanish]. Revista Espanola Endocrinologia Pediatrica 2016; 7(S1): 52-58.
2 Garcia-Solis P, Solis J, García-Gaytán A, Reyes-Mendoza V, Robles-Osorio L, Hernández-Montiel H, et al. Iodine nutrition status in pregnant women in Mexico. Thyroid 2011; 21: 1367-1371. DOI link, PMid:22029721
3 Mansourian AR. Thyroid function tests during first-trimester of pregnancy: a review of literature. Pakistan Journal of Biological Sciences 2010; 13(14): 664-673. DOI link, PMid:21848058
4 Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Role of thyroid hormone during early brain development. European Journal of Endocrinology 2004; 151(Suppl. 3): U25-U37. DOI link, PMid:15554884
5 Nazeri P, Shab-Bidar S, Pearce EN, Shariat M. Do maternal urinary iodine concentration or thyroid hormones within the normal range during pregnancy affect growth parameters at birth? A systematic review and meta-analysis. Nutrition Reviews 2020; 78(9): 747-763. DOI link, PMid:31923312
6 de Escobar GM, Obregón MJ, del Rey FE. Maternal thyroid hormones early in pregnancy and fetal brain development. Best Practice and Research Clinical Endocrinology and Metabolism 2004; 18(2): 225-248. DOI link, PMid:15157838
7 World Health Organization. Assessment of iodine deficiency disorders and monitoring their elimination: a guide for program managers. 3rd edn. World Health Organization, 2007. Available: web link
8 Mian C, Vitaliano P, Pozza D, Barollo S, Pitton M, Callegari G, et al. Iodine status in pregnancy: role of dietary habits and geographical origin. Clinical Endocrinology 2009; 70(5): 776-780. DOI link, PMid:18785991
9 Pino S, Fang S, Braverman LE. Ammonium persulfate: a safe alternative oxidizing reagent for measuring urinary iodine. Clinical Chemistry 1996; 42(2): 239-224.
10 Jones SA, Thoemke KR, Anderson GW. The role of thyroid hormone in fetal and neonatal brain development. Current Opinion in Endocrinology, Diabetes, and Obesity 2020; 12(1): 10-16.
11 Melse-Boonstra A, Jaiswal N. Iodine deficiency in pregnancy, infancy and childhood and its consequences for brain development. Best Practice and Research Clinical Endocrinology and Metabolism 2010; 24(1): 29-38. DOI link, PMid:20172468
12 Pharoah PO, Buttfield IH, Hetzel BS. Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet 1971; 297(7694): 308-310. DOI link, PMid:4100150
13 Qian M, Wang D, Watkins WE, Gebski V, Yan YQ, Li M, et al. The effects of iodine on intelligence in children: a meta-analysis of studies conducted in China. Asia Pacific Journal of Clinical Nutrition 2005; 14(1): 32-42.
14 Levier D, Korevaar TJM, Bath SC, Murcia M, Dineva M, Llop S et al. Association of maternal iodine status with child IQ: a meta-analysis of individual participant data. Journal of Clinical Endocrinology and Metabolism 2019; 104(12): 5957-5967. DOI link, PMid:30920622
15 Singh GR, Davison B, Ma GY, Eastman CJ, Mackerras DE. Iodine status of Indigenous and non-Indigenous young adults in the top end, before and after mandatory fortification. Medical Journal of Australia 2019; 210(3): 121-125. DOI link, PMid:30772938
16 Cobra C, Muhilal, Rusmil K, Rustama D, Djatnika, Suwardi SS, et al. Infant survival is improved by oral iodine supplementation. Journal of Nutrition 1997; 127(4): 574-578. DOI link, PMid:9109607
17 Eslava-Schmalbach J, Eslava-González L. Deficiencia de yodo en mujeres gestantes indígenas en Colombia: un problema de equidad y de salud pública. [In Spanish]. Revista Colombiana de Obstetricia y Ginecologia 2021; 72(1): 7-11.
18 Nazarpour S, Tehrani FR, Behboudi-Gandevavni S, Yarandi RB, Azizi F. Maternal urinary concentration and pregnancy outcomes in euthyroid pregnant women: a systematic review and meta-analysis. Biological Trace Element Research 2020; 197(2): 411-420. DOI link, PMid:31873919

You might also be interested in:

2012 - Cancer support services - are they appropriate and accessible for Indigenous cancer patients in Queensland, Australia?

2010 - Breast cancer stage at diagnosis and geographic access to mammography screening (New Hampshire, 1998-2004)

2009 - Disparity in cancer survival between urban and rural patients - how can clinicians help reduce it?

This PDF has been produced for your convenience. Always refer to the live site https://www.rrh.org.au/journal/article/8587 for the Version of Record.